Next Article in Journal
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System
Next Article in Special Issue
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells
Previous Article in Journal
Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871
Previous Article in Special Issue
ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming
 
 
Review

Article Versions Notes

Cancers 2021, 13(20), 5180; https://doi.org/10.3390/cancers13205180
Action Date Notes Link
article xml file uploaded 15 October 2021 14:40 CEST Original file -
article xml uploaded. 15 October 2021 14:40 CEST Update https://www.mdpi.com/2072-6694/13/20/5180/xml
article pdf uploaded. 15 October 2021 14:40 CEST Version of Record https://www.mdpi.com/2072-6694/13/20/5180/pdf
article html file updated 15 October 2021 14:41 CEST Original file -
article html file updated 30 July 2022 11:11 CEST Update https://www.mdpi.com/2072-6694/13/20/5180/html
Back to TopTop